Chengdu Yacht Bio-technology Co., Ltd

Chengdu Yacht Bio-technology is engaged in the R&D, production and sales of APIs, biological drugs and intermediates across therapeutic fields including anti-tumor, anti-infective and immune system treatments. Its subsidiary, Sichuan Novals Pharmaceuticals, upholds a quality-and-service-first principle to provide high-quality products and solutions, with main products including daptomycin, micafungin, caspofungin, everolimus, dalbavancin and anidulafungin.